Safety study of TVB-3567 for acne
Part of Skin clinical trials.
This early-stage study tests a new drug called TVB-3567, which may help treat acne. It checks the drug's safety and how the body processes it, first in healthy people and then in people with moderate to severe acne.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old.
- Your weight is within a healthy range (BMI between 18 and 37 for people with acne, or 18 to 32 for others).
- You are generally healthy, with no serious medical or mental health issues.
- If you have acne, it must be moderate to severe (doesn't include mild breakouts).
- You haven't used certain acne medications like tretinoin or isotretinoin recently.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental mRNA vaccine designed to help the immune system fight acne-causing bacteria. It's for adults with moderate or severe facial acne who are otherwise healthy, and it may offer a new way to treat acne beyond typical creams or pills.
This study tests a new acne treatment in adults. It aims to see if the treatment works well and is safe for people with acne.
This study tests a cosmetic product alongside a standard prescription acne treatment for 12 weeks, then a maintenance phase to see if the product helps improve acne and skin appearance.
This study is for people aged 18 to 25 with mild, moderate, or severe facial acne, and also for healthy volunteers without acne. Researchers want to learn more about acne by taking skin samples and blood samples, and no experimental treatments are given.
This trial tests an mRNA vaccine designed to target the bacteria that cause acne. It is for teenagers aged 12 to 17 with moderate to severe facial acne. The goal is to see if the vaccine is safe and may help reduce acne.
This trial tests an mRNA vaccine designed to treat mild facial acne. It aims to see if the vaccine is safe and effective at reducing acne lesions.
Hear when a new Acne trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.